The Valley Desk

NCT03744910 · Interventional trial

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

Overall registry status Terminated

Phase 3

Conditions Antibody-mediated Rejection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov